These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

549 related articles for article (PubMed ID: 32622370)

  • 1. PrEP awareness and engagement among transgender women in South Africa: a cross-sectional, mixed methods study.
    Poteat T; Malik M; van der Merwe LLA; Cloete A; Adams D; Nonyane BAS; Wirtz AL
    Lancet HIV; 2020 Dec; 7(12):e825-e834. PubMed ID: 32622370
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Experiences with HPTN 067/ADAPT Study-Provided Open-Label PrEP Among Women in Cape Town: Facilitators and Barriers Within a Mutuality Framework.
    Amico KR; Wallace M; Bekker LG; Roux S; Atujuna M; Sebastian E; Dye BJ; Elharrar V; Grant RM
    AIDS Behav; 2017 May; 21(5):1361-1375. PubMed ID: 27317411
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Strategies to Close the PrEP Uptake Gap Among Transgender People and Men Who Have Sex with Men in Tshwane, South Africa: Perspectives from the Community.
    Perez-Urbano I; Dilraj A; Pitsi A; Hlongwane N; Abdelatif N; Dietrich J; Ahmed K
    AIDS Behav; 2024 Jun; 28(6):1999-2014. PubMed ID: 38427124
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Engagement in the pre-exposure prophylaxis (PrEP) cascade among a respondent-driven sample of sexually active men who have sex with men and transgender women during early PrEP implementation in Zimbabwe.
    Parmley LE; Harris TG; Chingombe I; Mapingure M; Mugurungi O; Rogers JH; Gozhora P; Wu Y; Samba C; Musuka G; Hakim AJ
    J Int AIDS Soc; 2022 Feb; 25(2):e25873. PubMed ID: 35148029
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acceptability of HIV Pre-Exposure Prophylaxis Among Transgender Women in India: A Qualitative Investigation.
    Chakrapani V; Shunmugam M; Rawat S; Baruah D; Nelson R; Newman PA
    AIDS Patient Care STDS; 2020 Feb; 34(2):92-98. PubMed ID: 31951490
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retention, engagement, and adherence to pre-exposure prophylaxis for men who have sex with men and transgender women in PrEP Brasil: 48 week results of a demonstration study.
    Grinsztejn B; Hoagland B; Moreira RI; Kallas EG; Madruga JV; Goulart S; Leite IC; Freitas L; Martins LMS; Torres TS; Vasconcelos R; De Boni RB; Anderson PL; Liu A; Luz PM; Veloso VG;
    Lancet HIV; 2018 Mar; 5(3):e136-e145. PubMed ID: 29467098
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disparities of HIV risk and PrEP use among transgender women of color in South Florida.
    Holder CL; Perez-Gilbe HR; Fajardo FJ; Garcia S; Cyrus E
    J Natl Med Assoc; 2019 Dec; 111(6):625-632. PubMed ID: 31526532
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Young Transgender Women's Attitudes Toward HIV Pre-exposure Prophylaxis.
    Wood SM; Lee S; Barg FK; Castillo M; Dowshen N
    J Adolesc Health; 2017 May; 60(5):549-555. PubMed ID: 28132744
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preferences for Injectable PrEP Among Young U.S. Cisgender Men and Transgender Women and Men Who Have Sex with Men.
    Biello KB; Hosek S; Drucker MT; Belzer M; Mimiaga MJ; Marrow E; Coffey-Esquivel J; Brothers J; Mayer KH
    Arch Sex Behav; 2018 Oct; 47(7):2101-2107. PubMed ID: 28929260
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Gap Between Willingness and Uptake: Findings From Mixed Methods Research on HIV Prevention Among Black and Latina Transgender Women.
    Poteat T; Wirtz A; Malik M; Cooney E; Cannon C; Hardy WD; Arrington-Sanders R; Lujan M; Yamanis T
    J Acquir Immune Defic Syndr; 2019 Oct; 82(2):131-140. PubMed ID: 31180995
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interest in I-PrEP and Willingness to Participate in Clinical Trials Among Men and Transfeminine Persons Who have Sex with Men in Sub-Saharan Africa: Quantitative and Qualitative Findings from HPTN 075.
    Sandfort TGM; Kreniske P; Mbeda C; Reynolds D; Tshabalala G; Madiwati B; Ogendo A; Dominquez K; Panchia R; Gondwe D; Hamilton EL; Guo X; Cummings V
    AIDS Behav; 2024 Jul; 28(7):2361-2377. PubMed ID: 38761334
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A qualitative study to explore daily versus on-demand oral pre-exposure prophylaxis (PrEP) in young people from South Africa, Uganda and Zimbabwe.
    Dietrich JJ; Ahmed N; Tshabalala G; Wu M; Mulaudzi M; Hornschuh S; Atujuna M; Muhumuza R; Ssemata AS; Stranix-Chibanda L; Nematadzira T; Bekker LG; Martinson N; Seeley J; Fox J
    PLoS One; 2023; 18(6):e0287627. PubMed ID: 37384792
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The HIV care continuum for sexually active transgender women in three metropolitan municipalities in South Africa: findings from a biobehavioural survey 2018-19.
    Cloete A; Mabaso M; Savva H; van der Merwe LL; Naidoo D; Petersen Z; Kose Z; Mthembu J; Moyo S; Skinner D; Jooste S; Fellows IE; Shiraishi RW; Mwandingi SL; Simbayi LC
    Lancet HIV; 2023 Jun; 10(6):e375-e384. PubMed ID: 37119825
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pre-exposure prophylaxis (PrEP) awareness, attitudes and uptake willingness among young people: gender differences and associated factors in two South African districts.
    Shamu S; Shamu P; Khupakonke S; Farirai T; Chidarikire T; Guloba G; Nkhwashu N
    Glob Health Action; 2021 Jan; 14(1):1886455. PubMed ID: 33606603
    [No Abstract]   [Full Text] [Related]  

  • 15. Barriers and Facilitators to Oral PrEP Use Among Transgender Women in New York City.
    Rael CT; Martinez M; Giguere R; Bockting W; MacCrate C; Mellman W; Valente P; Greene GJ; Sherman S; Footer KHA; D'Aquila RT; Carballo-Diéguez A
    AIDS Behav; 2018 Nov; 22(11):3627-3636. PubMed ID: 29589137
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Awareness and Willingness to use HIV Pre-exposure Prophylaxis (PrEP) Among Trans Women in China: A Community-Based Survey.
    Yan L; Yan Z; Wilson E; Arayasirikul S; Lin J; Yan H; McFarland W
    AIDS Behav; 2021 Mar; 25(3):866-874. PubMed ID: 32989576
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Psychosocial determinants of pre-exposure prophylaxis use among pregnant adolescent girls and young women in Cape Town, South Africa: A qualitative study.
    Haribhai S; Khadka N; Mvududu R; Mashele N; Bekker LG; Gorbach P; Coates TJ; Myer L; Joseph Davey DL
    Int J STD AIDS; 2023 Jul; 34(8):548-556. PubMed ID: 36947792
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Experiences of oral pre-exposure prophylaxis use among heterosexual men accessing sexual and reproductive health services in South Africa: a qualitative study.
    Cholo FA; Dada S; Martin CE; Mullick S
    J Int AIDS Soc; 2024 May; 27(5):e26249. PubMed ID: 38695102
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A qualitative study to identify critical attributes and attribute-levels for a discrete choice experiment on oral pre-exposure prophylaxis (PrEP) delivery among young people in Cape Town and Johannesburg, South Africa.
    Dietrich JJ; Atujuna M; Tshabalala G; Hornschuh S; Mulaudzi M; Koh M; Ahmed N; Muhumuza R; Ssemata AS; Otwombe K; Bekker LG; Seeley J; Martinson NA; Terris-Prestholt F; Fox J
    BMC Health Serv Res; 2021 Jan; 21(1):17. PubMed ID: 33407395
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PrEP initiation and discontinuation among transgender women in the United States: a longitudinal, mixed methods cohort study.
    Cooney EE; Saleem HT; Stevenson M; Aguayo-Romero RA; Althoff KN; Poteat TC; Beckham SW; Adams D; Radix AE; Wawrzyniak AJ; Cannon CM; Schneider JS; Haw JS; Rodriguez AE; Mayer KH; Beyrer C; Reisner SL; Wirtz AL;
    J Int AIDS Soc; 2023 Dec; 26(12):e26199. PubMed ID: 38123897
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.